Cheung Lily bought PLRX
January 23, 2024 · Form 4 insider transaction
Cheung Lily bought 26,000 shares of Pliant Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
26,000
Price
$0.00
Total value
N/A
InsiderCheung Lily
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 23, 2024
Filing dateJanuary 24, 2024
Shares owned after26,795
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.; Includes 795 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.